Ispire Technology Inc. (ISPR.US) emphasized today that the U.S. Food and Drug Administration's (FDA) newly released draft guidance on evidence requirements for Premarket Tobacco Product Applications (PMTAs) for flavored Electronic Nicotine Delivery Systems (ENDS) creates substantial economic value for its shareholders and unlocks a multi-billion dollar market opportunity. The guidance outlines the evidence standards and regulatory expectations for flavored e-cigarette products seeking PMTA approval. By providing a legal and compliant pathway to market for flavored e-cigarettes, the FDA's guidance effectively opens up a potential addressable market of approximately $50 billion, a market where the majority of products are currently unapproved or sold illegally. IKE Tech LLC ("IKE Tech" or "IKE"), a joint venture in which Ispire holds a 40% stake, possesses a unique competitive advantage in this market and is well-positioned to benefit. IKE's SaaS recurring revenue model is projected to generate between $5 million and $20 million in annual revenue per customer. Management believes that even securing a limited number of customers could value the IKE joint venture in the hundreds of millions of dollars, creating a highly valuable asset on Ispire's balance sheet. This guidance marks the FDA's first formal establishment of an evaluation framework for flavored e-cigarette products and explicitly notes that device-level access control technologies may be considered as factors in determining whether a product meets the "appropriate for the protection of public health" standard required for PMTA approval. The draft guidance points out that Device Access Restriction (DAR) technologies, such as biometric authentication, geofencing, and persistent age verification, could serve as potential safety measures to prevent youth access to ENDS devices. Simultaneously, the FDA emphasized that traditional protective measures, such as local age restriction laws or point-of-sale (POS) age verification, if used alone, may be insufficient to effectively reduce youth e-cigarette use because they cannot directly prevent minors from using the devices. "Ispire believes this guidance represents a significant step towards a technology-supported regulatory framework for vaping products," stated Michael Wang, Co-CEO of Ispire. "The FDA's recognition of Device Access Restrictions (DAR) also validates our long-held view that persistent, device-level age verification protects youth while preserving adult choice." Ispire has consistently advocated for technology-driven youth prevention solutions. Through the IKE Tech LLC joint venture, of which it is a founding partner, Ispire supports the development of advanced identification and authentication systems designed to control device access directly at the point of use, rather than solely at the point of sale. Ispire currently holds a 40% equity stake in the IKE joint venture. In 2025, IKE Tech submitted the first PMTA for an independent age verification technology component. This technology is a standalone, interoperable age verification solution compatible with various ENDS devices, intended for integration into a wide range of e-cigarette products. The platform combines Bluetooth Low Energy (BLE) chips, biometric authentication, and blockchain-based identity verification to ensure only verified adult users can activate a device. In a multi-center Human Factors Validation Study submitted with the PMTA, IKE's age-gating technology demonstrated the following results: 100% effectiveness in preventing minors from activating a device; 100% accuracy in demographic identity verification; a user operational error rate of less than 1%, indicating ease of use for adults; and 91% user satisfaction with the application's simplicity and functionality. Beyond age verification, the IKE technology platform can also support product authentication and anti-counterfeiting features, helping manufacturers and regulators identify illegal or counterfeit devices that bypass regulations, evade taxes, and endanger consumer safety. The FDA's draft guidance could immediately open access to a multi-billion dollar segment of the U.S. e-cigarette market. Given that flavors like fruit constitute a significant portion of consumer demand, the FDA's endorsement of DAR technology provides a potential pathway for compliant manufacturers to enter a market segment currently dominated by illicit products. Industry estimates suggest that approximately 70% of the current U.S. e-cigarette market consists of illegal or unauthorized products. Data indicates that when these hard-to-track illegal and unauthorized products are included, the total U.S. e-cigarette market is currently worth about $50 billion annually. IKE's technological solution would enable companies to access and serve this vast total market. Over recent months, IKE Tech has been actively collaborating with major tobacco companies, leading independent brands, and several of the world's largest e-cigarette manufacturers to evaluate the feasibility of integrating its technology into PMTAs for flavored products. The company has also received strong interest from multiple manufacturers seeking to bring compliant flavored products to the U.S. market. Following the FDA's guidance, Ispire believes this regulatory framework could also influence global policies, potentially leading other major markets to adopt requirements for device-level age verification technology in e-cigarette products. IKE's business model is designed as a recurring compliance technology platform, generating SaaS-based recurring revenue from manufacturers who integrate the system into their devices. Each customer adopting the technology is expected to generate approximately $5 million to $20 million in annual recurring SaaS revenue for IKE, in addition to per-device hardware sales or firmware licensing fees. Even if only a limited number of authorized flavored products adopt IKE's technology, it has the potential to create significant enterprise value for the platform.